-
1دورية أكاديمية
المؤلفون: Petersen, E, Maeurer, M, Marais, B, Migliori, GB, Mwaba, P, Ntoumi, F, Vilaplana, C, Kim, K, Schito, M, Zumla, A
المصدر: International Journal of Infectious Diseases , 56 pp. 1-5. (2017)
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, TUBERCULOSIS
وصف الملف: text
العلاقة: https://discovery.ucl.ac.uk/id/eprint/1551406/1/Zumla_1-s2.0-S1201971217300590-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/1551406Test/
-
2دورية أكاديمية
المؤلفون: Abubakar, I, Zignol, M, Falzon, D, Raviglione, M, Ditiu, L, Masham, S, Adetifa, L, Ford, N, Cox, H, Lawn, SD, Marais, BJ, McHugh, TD, Mwaba, P, Bates, M, Lipman, M, Zijenah, L, Logan, S, McNerney, R, Zumla, A, Sarda, K, Nahid, P, Hoelscher, M, Pletschette, M, Memish, ZA, Kim, P, Hafner, R, Cole, S, Migliori, GB, Maeurer, M, Schito, M
المصدر: The Lancet Infectious Diseases , 13 (6) pp. 529-539. (2013)
مصطلحات موضوعية: science & technology, life sciences & biomedicine, infectious diseases, new-york-city, mycobacterium-tuberculosis, multidrug-resistance, treatment outcomes, mdr-tb, pulmonary tuberculosis, infection-control, european region, united-states, risk-factors
وصف الملف: text
العلاقة: https://discovery.ucl.ac.uk/id/eprint/1389237/1/Abubakar_1-s2.0-S1473309913700306-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/1389237Test/
-
3دورية أكاديمية
المؤلفون: Allix-Beguec, C, Arandjelovic, I, Bi, L, Beckert, P, Bonnet, M, Bradley, P, Cabibbe, AM, Cancino-Munoz, I, Caulfield, MJ, Chaiprasert, A, Cirillo, DM, Clifton, D, Comas, I, Crook, DW, De Filippo, MR, De Neeling, H, Diel, R, Drobniewski, FA, Faksri, K, Farhat, MR, Fleming, J, Fowler, P, Fowler, TA, Gao, Q, Gardy, J, Gascoyne-Binzi, D, Gibertoni-Cruz, A-L, Gil-Brusola, A, Golubchik, T, Gonzalo, X, Grandjean, L, He, G, Guthrie, JL, Hoosdally, S, Hunt, M, Iqbal, Z, Ismail, N, Johnston, J, Khanzada, FM, Khor, CC, Kohl, TA, Kong, C, Lipworth, S, Liu, Q, Maphalala, G, Martinez, E, Mathys, V, Merker, M, Miotto, P, Mistry, N, Moore, DAJ, Murray, M, Niemann, S, Ong, RT-H, Peto, TEA, Posey, JE, Prammananan, T, Pym, A, Rodrigues, C, Rodrigues, M, Rodwell, T, Rossolini, GM, Padilla, ES, Schito, M, Shen, X, Shendure, J, Sintchenko, V, Sloutsky, A, Smith, EG, Snyder, M, Soetaert, K, Starks, AM, Supply, P, Suriyapol, P, Tahseen, S, Tang, P, Teo, Y-Y, Thuong, TNT, Thwaites, G, Tortoli, E, Omar, S, Van Soolingen, D, Walker, AS, Walker, TM, Wilcox, M, Wilson, DJ, Wyllie, D, Yang, Y, Zhang, H, Zhao, Y, Zhu, B
المصدر: 1415 ; 1403
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, RESISTANT TUBERCULOSIS, MULTIDRUG-RESISTANCE, XPERT MTB/RIF, TRANSMISSION, MUTATIONS, DIAGNOSIS, Antitubercular Agents, Drug Resistance, Bacterial, Ethambutol, Genome, Genotype, Humans, Isoniazid, Microbial Sensitivity Tests, Mutation, Mycobacterium tuberculosis, Phenotype, Pyrazinamide, Rifampin, Tuberculosis, Whole Genome Sequencing, CRyPTIC Consortium and the 100,000 Genomes Project, 11 Medical And Health Sciences
العلاقة: New England Journal of Medicine; http://hdl.handle.net/10044/1/64939Test; https://x.doi.org/10.1056/NEJMoa1800474Test
-
4
المؤلفون: Zumla, A, Maeurer, M, Chakaya, J, Hoelscher, M, Ntoumi, F, Rustomjee, R, Vilaplana, C, Yeboah-Manu, D, Rasolofo, V, Munderi, P, Singh, N, Aklillu, E, Padayatchi, N, Macete, E, Kapata, N, Mulenga, M, Kibiki, G, Mfinanga, S, Nyirenda, T, Mboko, L, Garcia-Basteiro, AL, Rakotosamimanana, N, Bates, M, Mwaba, P, Reither, K, Gagneux, S, Edwards, S, Mfinanga, E, Abdulla, S, Cardona, P-J, Russell, JBW, Gant, V, Noursadeghi, M, Elkington, P, Bonnet, M, Menendez, C, Dieye, TN, Diarra, B, Maiga, A, Aseffa, A, Parida, S, Wejse, C, Petersen, E, Kaleebu, P, Oliver, M, Craig, G, Corrah, T, Tientcheu, L, Antonio, M, McHugh, TD, Sheikh, A, Ippolito, G, Ramjee, G, Kaufmann, SHE, Churchyard, G, Steyn, AJC, Grobusch, MP, Sanne, I, Martinson, N, Mandansein, R, Wilkinson, RJ, Wallis, RS, Mayosi, B, Schito, M
مصطلحات موضوعية: Time Factors, PULMONARY TUBERCULOSIS, Immunology, Antitubercular Agents, REGIMENS, Microbiology, host-directed therapy, PARTNERSHIPS, Tuberculosis, Multidrug-Resistant, DRUGS, Humans, MOXIFLOXACIN, DEVELOPING-COUNTRIES, Precision Medicine, SUB-SAHARAN AFRICA, Host-Directed Therapies Network (HDT-NET) Consortium, Science & Technology, treatment, repurposed drugs, multi-drug resistant tuberculosis, Mycobacterium tuberculosis, 11 Medical And Health Sciences, 06 Biological Sciences, Combined Modality Therapy, ADJUNCT THERAPIES, OPPORTUNITIES, Infectious Diseases, TRIALS, tuberculosis, Life Sciences & Biomedicine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1032::cd4225445b9ea567aa9c53a9938647b7Test
http://hdl.handle.net/10044/1/51747Test